Arcticzymes Technologies ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Arcticzymes Technologies ASA with three other
pharmaceutical manufacturers in Europe:
Diod PAO
of RUSSIAN FEDERATION
(2019
sales of 657.75 million Russian Rubles [US$8.54 million]
),
Nicox SA
of FRANCE
(6.86 million Euros [US$7.99 million]
), and
Norda ASA
(83.94 million Norwegian Kroner [US$8.84 million]
).
Sales Analysis.
During the year ended December of 2019, sales at
Arcticzymes Technologies ASA were NOK 77.25 million (US$8.14 million).
This
is
an
increase of 15.7%
versus 2018, when the company's sales were NOK 66.77 million.
Sales of Enzymes saw an increase
that was more than double the company's growth rate: sales were up
31.7% in 2019, from
NOK 34.30 million to NOK 45.19 million.
Not all segments of Arcticzymes Technologies ASA experienced an increase in sales in 2019:
sales of Betaglucans fell 1.2% to NOK 32.06 million.